image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 21.37
-0.326 %
$ 1.83 B
Market Cap
37.49
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PGNY stock under the worst case scenario is HIDDEN Compared to the current market price of 21.4 USD, Progyny, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PGNY stock under the base case scenario is HIDDEN Compared to the current market price of 21.4 USD, Progyny, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PGNY stock under the best case scenario is HIDDEN Compared to the current market price of 21.4 USD, Progyny, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PGNY

image
$24.0$24.0$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
1.17 B REVENUE
7.22%
67.5 M OPERATING INCOME
8.48%
54.3 M NET INCOME
-12.41%
179 M OPERATING CASH FLOW
-5.14%
196 M INVESTING CASH FLOW
197.64%
-310 M FINANCING CASH FLOW
-2698.77%
298 M REVENUE
4.12%
15.8 M OPERATING INCOME
26.72%
10.5 M NET INCOME
1.07%
52.2 M OPERATING CASH FLOW
17.18%
75 M INVESTING CASH FLOW
388.15%
-56.3 M FINANCING CASH FLOW
11.09%
Balance Sheet Progyny, Inc.
image
Current Assets 473 M
Cash & Short-Term Investments 228 M
Receivables 235 M
Other Current Assets 9.44 M
Non-Current Assets 134 M
Long-Term Investments 0
PP&E 29.6 M
Other Non-Current Assets 105 M
37.55 %38.76 %4.88 %17.25 %Total Assets$607.1m
Current Liabilities 169 M
Accounts Payable 95.1 M
Short-Term Debt 2.86 M
Other Current Liabilities 70.7 M
Non-Current Liabilities 16.4 M
Long-Term Debt 16.4 M
Other Non-Current Liabilities 0
51.39 %38.19 %8.87 %Total Liabilities$185.0m
EFFICIENCY
Earnings Waterfall Progyny, Inc.
image
Revenue 1.17 B
Cost Of Revenue 914 M
Gross Profit 253 M
Operating Expenses 186 M
Operating Income 67.5 M
Other Expenses 13.1 M
Net Income 54.3 M
1b1b1b1b800m800m600m600m400m400m200m200m001b(914m)253m(186m)67m(13m)54mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
21.71% GROSS MARGIN
21.71%
5.78% OPERATING MARGIN
5.78%
4.66% NET MARGIN
4.66%
12.87% ROE
12.87%
8.95% ROA
8.95%
9.98% ROIC
9.98%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Progyny, Inc.
image
200m200m180m180m160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)2018201820192019202020202021202120222022202320232024202420252025
Net Income 54.3 M
Depreciation & Amortization 3.18 M
Capital Expenditures -5.4 M
Stock-Based Compensation 128 M
Change in Working Capital 0
Others 3.92 M
Free Cash Flow 174 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Progyny, Inc.
image
Wall Street analysts predict an average 1-year price target for PGNY of $26.5 , with forecasts ranging from a low of $18 to a high of $41 .
PGNY Lowest Price Target Wall Street Target
18 USD -15.77%
PGNY Average Price Target Wall Street Target
26.5 USD 24.01%
PGNY Highest Price Target Wall Street Target
41 USD 91.86%
Price
Max Price Target
Min Price Target
Average Price Target
45454040353530302525202015151010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership Progyny, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
11.3 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
457 K USD 2
Bought
0 USD 0
0-3 MONTHS
5.24 M USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Why Progyny (PGNY) is Poised to Beat Earnings Estimates Again Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 1 week ago
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building The leadership additions support the company's continued ability to scale as it delivers the right care model for women's health and family building globenewswire.com - 2 weeks ago
Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week® As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges globenewswire.com - 2 weeks ago
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today announced the launch of their 2025 Awareness, Hope, and Activism (AHA) Grant, marking the fourth consecutive year of this family building partnership. globenewswire.com - 3 weeks ago
Progyny Expands Maternal Health Support with Addition of Doula Services Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes Available to employers and health plans, the in-person and virtual doula care services can close more care gaps and improve health outcomes globenewswire.com - 1 month ago
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation globenewswire.com - 1 month ago
Progyny, Inc. to Participate in Upcoming Investor Conferences NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025. globenewswire.com - 1 month ago
PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint Pete Anevski, CEO of Progyny (PGNY), discusses his company's latest earnings and how it's poised for a "well-positioned" year. He notes general healthcare headwinds for the women's health company, though he expects Progyny to find new clients and retain current customers. youtube.com - 1 month ago
Progyny Tops EPS Forecast, Eyes Growth Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27. The standout points were its impressive revenue and adjusted earnings per share (EPS) results, both of which surpassed analysts' consensus predictions. fool.com - 2 months ago
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call. seekingalpha.com - 2 months ago
Progyny, Inc. Announces Fourth Quarter 2024 Results Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth globenewswire.com - 2 months ago
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 months ago
8. Profile Summary

Progyny, Inc. PGNY

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.83 B
Dividend Yield 0.00%
Description Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Contact 1359 Broadway, New York, NY, 10018 https://www.progyny.com
IPO Date Oct. 25, 2019
Employees 675
Officers Mr. Peter Anevski CPA Chief Executive Officer & Director Ms. Allison Swartz Executive Vice President, General Counsel & Secretary Mr. David J. Schlanger J.D. Executive Chairman Mr. Mark S. Livingston CPA Chief Financial Officer Mr. Michael Sturmer President